Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

Doxycycline for community treatment of suspected COVID-19 in people at high risk of adverse outcomes in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

<p><strong>Background</strong></p> Doxycycline is often used for treating COVID-19 respiratory symptoms in the community despite an absence of evidence from clinical trials to support its use. We aimed to assess the efficacy of doxycycline to treat suspected COVID-19 in the c...

Descripció completa

Dades bibliogràfiques
Autors principals:	Butler, CC, Yu, L-M, Dorward, J, Gbinigie, O, Hayward, G, Saville, BR, Van Hecke, O, Berry, N, Detry, MA, Saunders, C, Fitzgerald, M, Harris, V, Djukanovic, R, Gadola, S, Kirkpatrick, J, Ogburn, E, Patel, MG, de Lusignan, S, Evans, PH, Thomas, NPB, Hobbs, FDR
Altres autors:	PRINCIPLE Trial Collaborative Group
Format:	Journal article
Idioma:	English
Publicat:	Elsevier 2021

Ítems similars

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
per: PRINCIPLE Trial Collaborative Group, et al.
Publicat: (2021)

Inhaled budesonide for COVID-19 in people at higher risk of adverse outcomes in the community: interim analyses from the PRINCIPLE trial
per: Yu, L-M, et al.
Publicat: (2021)

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
per: Yu, L-M, et al.
Publicat: (2021)

Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
per: PRINCIPLE Trial Collaborative Group, et al.
Publicat: (2021)

Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
per: Dorward, J, et al.
Publicat: (2022)

Inhaled budesonide for COVID-19 in people at higher risk of complications in the community: the UK National Community Randomi
per: Gbinigie, O, et al.
Publicat: (2023)

Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
per: Hayward, G, et al.
Publicat: (2021)

Ivermectin for COVID-19 in adults in the community (PRINCIPLE): an open, randomised, controlled, adaptive platform trial of short- and longer-term outcomes
per: Hayward, G, et al.
Publicat: (2024)

High-dose budesonide for early COVID-19 - Authors' reply
per: Hobbs, FDR, et al.
Publicat: (2021)

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship
per: de Lusignan, S, et al.
Publicat: (2021)

The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: A rapid review
per: Dorward, J, et al.
Publicat: (2021)

Inclusion and diversity in the PRINCIPLE trial
per: Patel, MG, et al.
Publicat: (2021)

Suspected Doxycycline Induced Acute Interstitial Nephritis
per: Andrew Abrahamian, et al.
Publicat: (2023-05-01)

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship: a retrospective sentinel network cohort study.
per: de Lusignan, S, et al.
Publicat: (2021)

Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: A randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU).
per: Raja Dhar, et al.
Publicat: (2023-01-01)

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
per: Butler, CC, et al.
Publicat: (2022)

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): preliminary analysis from the united kingdom randomised, controlled open-label, platform adaptive trial
per: Butler, C, et al.
Publicat: (2022)

A targeted approach to vaccine hesitancy
per: Leston, M, et al.
Publicat: (2023)

PRINCIPLE trial demonstrates scope for in-pandemic improvement in primary care antibiotic stewardship: a retrospective sentinel network cohort study
per: Simon de Lusignan, et al.
Publicat: (2021-10-01)

Penetration of doxycycline in aqueous humour
per: Kulshrestha O, et al.
Publicat: (1981-01-01)

Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
per: Sarah Tonkin-Crine, et al.
Publicat: (2021-06-01)

Excess mortality from COVID-19 in an English sentinel network population
per: Joy, M, et al.
Publicat: (2020)

Doxycycline prophylaxis in malaria.
per: Gilks, C, et al.
Publicat: (1987)

Doxycycline induced Esophagitis
per: Banu Karakus Yilmaz, et al.
Publicat: (2014-02-01)

Comparison between Efficacy of Ciprofioxacin -Doxycycline with Rifampin – Doxycycline Regimens inrelapse of Brucellosis
per: Hossein Sarmadian, et al.
Publicat: (2014-08-01)

A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis.
per: Chaowagul, W, et al.
Publicat: (1999)

Transdermal Delivery System of Doxycycline-Loaded Niosomal Gels: Toward Enhancing Doxycycline Stability
per: Ahlam Zaid Alkilani, et al.
Publicat: (2024-07-01)

Effect of doxycycline and doxycycline with carica papaya on thrombocytopenia and leucopenia in acute dengue fever patients
per: Vivek Pambhar, et al.
Publicat: (2022-01-01)

Different Concentrations of Doxycycline in Swine Manure Affect the Microbiome and Degradation of Doxycycline Residue in Soil
per: Qiufan Yan, et al.
Publicat: (2018-12-01)

Treatment of Morgellons disease with doxycycline
per: Jeff F. Zhang, et al.
Publicat: (2021-12-01)

Actinic granuloma responding to doxycycline
per: George M. Jeha, BS, et al.
Publicat: (2020-11-01)

Doxycycline in the current clinical practice
per: Zyryanov S.K., et al.
Publicat: (2020-03-01)

Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
per: Gbinigie, O, et al.
Publicat: (2023)

Evaluation of the doxycycline release from AH26 sealer-doxycycline combination: An ex vivo study
per: Kazem Ashofteh Yazdi, et al.
Publicat: (2011-09-01)

Doxycycline promotes proteasome fitness in the central nervous system
per: Edmund Charles Jenkins, et al.
Publicat: (2021-08-01)

Experiences of urine collection devices during suspected Urinary Tract Infections: qualitative study
per: Glogowska, M, et al.
Publicat: (2023)

Doxycycline PEP can induce doxycycline resistance in Klebsiella pneumoniae in a Galleria mellonella model of PEP
per: Chris Kenyon, et al.
Publicat: (2023-08-01)

Scrub typhus and the misconception of doxycycline resistance
per: Wangrangsimakul, T, et al.
Publicat: (2019)

Doxycycline Degradation by the Oxidative Fenton Process
per: Alexandre A. Borghi, et al.
Publicat: (2015-01-01)

Use of doxycycline in modern clinical practice
per: R. S. Kozlov, et al.
Publicat: (2014-12-01)